Accretion Nutraveda
add_icon

Accretion Nutraveda

274.70
0.00
(0.00%)
Market Cap
198.90 Cr
PE Ratio
-
Volume
0.00
Day High - Low
- - -
52W High-Low
300.00 - 150.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
198.90 Cr
EPS
9.35
PE Ratio
-
PB Ratio
6.48
Book Value
42.41
EBITDA
6.89
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
48.85
Debt to Equity
0.94
Forecast For
Actual

Company News

View All News
Caret
neutral
Accretion Nutraveda Limited has scheduled a board meeting on May 8, 2026, to consider and approve audited financial results for the year ended March 31, 2026.
neutral
Accretion Nutraveda Limited filed its quarterly certificate under SEBI Regulation 74(5) for Q4FY26, confirming all shares remain in dematerialized form with no rematerialization requests received during the period.
neutral
Accretion Nutraveda Limited notifies BSE about Corporate Identification Number update from U24290GJ2021PLC121216 to L24290GJ2021PLC121216 following its equity shares listing on BSE SME Exchange on 04th February, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,861.50
#1 4,46,636.20
39.96
#1 54,729.00
9.71
#1 10,980
16.07
58.45
6,923.00
1,83,783.90
72.74
9,712.00
18.67
2,191
-1.02
72.69
4,381.80
1,48,300.02
63.98
11,539.40
6.99
1,911
26.24
52.52
1,439.90
1,16,312.34
27.76
27,711.70
-2.46
3,783
-55.32
56.75
1,303.20
1,08,770.68
25.40
33,593.30
-0.44
3,998
-86.05
47.13
2,269.90
1,03,744.24
18.91
27,487.50
19.98
5,345
#1 87.72
38.38
2,454.70
1,01,331.26
55.11
12,744.20
20.90
2,007
7.65
67.26
994.00
1,00,019.66
#1 18.80
23,511.00
18.55
4,615
-0.32
55.29
1,514.60
87,968.21
24.96
32,345.60
9.43
3,484
7.59
71.98
1,308.90
70,661.83
77.65
6,812.90
#1 21.03
884
21.18
76.81
Growth Rate
Revenue Growth
108.70 %
Net Income Growth
95.00 %
Cash Flow Change
-1,060.87 %
ROE
-35.52 %
ROCE
-28.89 %
EBITDA Margin (Avg.)
-13.10 %

Yearly Financial Results

Annual Financials
2023
2024
2025
2026
TTM
Revenue
3
5
16
34
0
Expenses
2
4
12
27
0
EBITDA
1
1
4
7
0
Operating Profit %
21 %
24 %
23 %
21 %
0 %
Depreciation
0
0
0
0
0
Interest
0
0
0
1
0
Profit Before Tax
0
1
3
6
0
Tax
0
0
1
1
0
Net Profit
0
1
3
5
0
EPS in ₹
7.79
22.83
71.91
9.35
0.00

Balance Sheet

Balance Sheet
2023
2024
2025
2026
Total Assets
4
5
11
42
Fixed Assets
2
1
2
2
Current Assets
3
3
9
36
Capital Work in Progress
0
0
0
0
Investments
0
0
0
9
Other Assets
3
3
9
0
Total Equity & Liabilities
4
5
11
42
Current Liabilities
2
3
4
3
Non Current Liabilities
1
1
2
4
Total Equity
0
1
5
36
Reserve & Surplus
-0
1
5
28
Share Capital
0
0
1
7

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
0
0
-0
Investing Activities
0
-0
-1
Operating Activities
1
0
-2
Financing Activities
-1
0
3

Share Holding

% Holding
Sept 2025
Jan 2026
Feb 2026
Promoter
100.00 %
100.00 %
73.48 %
FIIs
0.00 %
0.00 %
6.04 %
DIIs
0.00 %
0.00 %
6.51 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
10.48 %
Others
0.00 %
0.00 %
3.49 %
No of Share Holders
10
10
407

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
08 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 May 2026 267.50 271.70

Announcements

Appointment Of Internal Auditors5 days ago
Appointment Of Secretarial Auditors5 days ago
Announcement under Regulation 30 (LODR)-Change in Management5 days ago
Announcement under Regulation 30 (LODR)-Change in Management5 days ago
Announcement under Regulation 30 (LODR)-Resignation of Director5 days ago
Announcement under Regulation 30 (LODR)-Resignation of Director5 days ago
Board Meeting Outcome for Outcome Of Board Meeting Financial Results 31St March 20265 days ago
Board Meeting Intimation for Board Meeting Intimation For Consider And Approve Audited Financial Results For The Year Ended On 31St March 2026May 01, 2026
Clarification On Price MovementApr 30, 2026
Clarification sought from Accretion Nutraveda LtdApr 29, 2026
Confirmation Regarding Non-Applicability Of Large Corporate Disclosure RequirementsApr 29, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Apr 27, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2026
Intimation For Change Of Corporate Identification Number (CIN) Of The Company.Apr 01, 2026
Closure of Trading WindowMar 28, 2026
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 26, 2026
Appointment Of Internal AuditorsMar 26, 2026
Board Meeting Outcome for Outcome Of The Board MeetingMar 26, 2026
Clarification On Price MovementFeb 20, 2026
Clarification sought from Accretion Nutraveda LtdFeb 19, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 17, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 07, 2026
Listing of Equity Shares of Accretion Nutraveda LtdFeb 04, 2026

Technical Indicators

RSI(14)
Neutral
68.35
ATR(14)
Less Volatile
20.48
STOCH(9,6)
Neutral
75.42
STOCH RSI(14)
Neutral
79.37
MACD(12,26)
Bullish
4.82
ADX(14)
Strong Trend
37.25
UO(9)
Bearish
59.18
ROC(12)
Uptrend And Accelerating
35.99
WillR(14)
Neutral
-25.56